Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer-Reference-Cited by-同舟云学术

Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer

Published:2022-03 Issue: Volume:163 Page:177-179
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Debie Yana,Vandamme Timon,Goossens Maria E.,van Dam Peter A.,Peeters Marc

Funder

Belgian Federal Government

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference10 articles.

1. Immunoglobin G/total antibody testing for SARS-CoV-2: a prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests;van Dam;Eur J Cancer,2021

2. Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment;Peeters;ESMO Open,2021

3. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients;Kamar;N Engl J Med,2021

4. Antibody titers before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged ≥60 years;Eliakim-Raz;JAMA,2021

5. Efficacy of SARS-CoV-2 vaccine in thoracic cancer patients: a prospective study supporting a third dose in patients with minimal serologic response after two vaccine doses;Gounant;J Thorac Oncol: Off Publ Int Assoc Study Lung Canc,2021

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term effects of the COVID-19 pandemic for patients with cancer;Quality of Life Research;2024-07-03

2. Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients: a systematic review and meta-analysis;Virology Journal;2024-05-03

3. Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects;Frontiers in Immunology;2024-01-26

4. Infection with alternate frequencies of SARS-CoV-2 vaccine boosting for patients undergoing antineoplastic cancer treatments;JNCI: Journal of the National Cancer Institute;2023-08-21

5. COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future;The Journal of Infectious Diseases;2023-08-01